| Product NDC: | 0049-2710 |
| Proprietary Name: | Cardura |
| Non Proprietary Name: | doxazosin mesylate |
| Active Ingredient(s): | 4 mg/1 & nbsp; doxazosin mesylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, MULTILAYER, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0049-2710 |
| Labeler Name: | Roerig |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021269 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050222 |
| Package NDC: | 0049-2710-30 |
| Package Description: | 30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (0049-2710-30) |
| NDC Code | 0049-2710-30 |
| Proprietary Name | Cardura |
| Package Description | 30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (0049-2710-30) |
| Product NDC | 0049-2710 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | doxazosin mesylate |
| Dosage Form Name | TABLET, MULTILAYER, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20050222 |
| Marketing Category Name | NDA |
| Labeler Name | Roerig |
| Substance Name | DOXAZOSIN MESYLATE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |